Understanding the earliest immune responses following HIV infection is critical to inform
future vaccines and therapeutics. Here, we review recent prospective human studies in at …

Our understanding of the B-cell subsets found in human blood and their functional
significance has advanced greatly in the past decade. This has been aided by the evolution …

An expansion of CD21 low B cells has been described in a variety of diseases associated
with persistent immune stimulation as in chronic infection, immunodeficiency, or …

Failures to produce neutralizing antibodies upon HIV‐1 infection result in part from B‐cell
dysfunction due to unspecific B‐cell activation. How HIV‐1 affects antigen‐specific B‐cell …

Human immunodeficiency virus type 1 (HIV‐1) infection causes considerable morbidity and
mortality worldwide. Although antiretroviral therapy (ART) has largely transformed HIV …

Non-Hodgkin lymphoma is the most common malignancy affecting people living with HIV
(PLWH). Among its several subtypes, diffuse large B-cell lymphoma (DLBCL) is an important …

T follicular helper (Tfh) cells and their interactions with B cells within the germinal center play
extensive roles in human immunodeficiency virus (HIV) pathology. However, their …

Background Data on seroconversion rates following yellow fever (YF) vaccine and effect of
revaccination in people living with HIV (PLWH) are scarce. We aimed at determining key …

Time to AIDS in HIV-2 infection is approximately twice as long compared to in HIV-1
infection. Despite reduced viremia, HIV-2-infected individuals display signs of chronic …

Although peripheral B cell dysfunction in early HIV infection is established, how B cell
subsets are altered by HIV infection is poorly understood. While investigating B cell subsets …